{"title":"A Review of Energy-Based Device Interventions to Treat Keloid Scars.","authors":"Hira Ghani, Alicia Podwojniak, Sasha Ghofrani, Isabella Tan, Rebecca Fliorent, Khalil Khatri","doi":"10.36849/JDD.8210","DOIUrl":null,"url":null,"abstract":"<p><p>Keloids are thickened raised scars that develop due to injury and grow beyond the boundaries of their original wound, mostly affecting individuals with skin of color. This review explores the use of energy-based devices to treat keloids, both using laser monotherapy and in combination with other drugs. Laser therapy alone has shown efficacy in treating keloids. Combination laser therapy has better keloid reduction when administered with steroids, 5-fluorouracil (5-FU), and verapamil. However, monotherapy has had less adverse reactions including dermal atrophy and local pain. Therefore, physician discretion is essential when considering treatment. This review highlights the efficacy of energy-based devices (EBDs), alone and in combination. It also reveals the need to have tailored approaches with patients. Further research is needed to develop more comprehensive treatment standards for keloids using EBDs alone or in combination. J Drugs Dermatol. 2024;23(11):998-1002. doi:10.36849/JDD.8210R1.</p>","PeriodicalId":15566,"journal":{"name":"Journal of Drugs in Dermatology","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drugs in Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36849/JDD.8210","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Keloids are thickened raised scars that develop due to injury and grow beyond the boundaries of their original wound, mostly affecting individuals with skin of color. This review explores the use of energy-based devices to treat keloids, both using laser monotherapy and in combination with other drugs. Laser therapy alone has shown efficacy in treating keloids. Combination laser therapy has better keloid reduction when administered with steroids, 5-fluorouracil (5-FU), and verapamil. However, monotherapy has had less adverse reactions including dermal atrophy and local pain. Therefore, physician discretion is essential when considering treatment. This review highlights the efficacy of energy-based devices (EBDs), alone and in combination. It also reveals the need to have tailored approaches with patients. Further research is needed to develop more comprehensive treatment standards for keloids using EBDs alone or in combination. J Drugs Dermatol. 2024;23(11):998-1002. doi:10.36849/JDD.8210R1.
期刊介绍：
The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology.
We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality.
Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
